We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.75B
AUM Growth
+$110M
(+6.7%)
Cap. Flow
+$55.5M
Cap. Flow
% of AUM
3.18%
Top 10 Holdings %
Top 10 Hldgs %
33.48%
Holding
1,098
New
45
Increased
357
Reduced
314
Closed
132
Avg Time Held
3.5
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$27.5M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$27.4M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$11.5M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.59M |
| 5 |
iShares Frontier and Select EM ETF
FM
|
+$8.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$31.6M |
| 2 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$30M |
| 3 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$9.76M |
| 4 |
VanEck Morningstar Wide Moat ETF
MOAT
|
+$3.9M |
| 5 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$3.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.43% |
| 2 | Technology | 6.82% |
| 3 | Healthcare | 4.4% |
| 4 | Financials | 4.36% |
| 5 | Energy | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
ConocoPhillips
COP
$170B
| $10.7M | 0.61% |
107,805
-205
| -0.2% | -$22.4K |
2018 Q1
20 quarters
|
|
|
27
Vanguard Short-Term Bond ETF
BSV
$45.5B
| $10.5M | 0.6% |
137,446
+113,393
| +471% | +$8.59M |
2017 Q2
23 quarters
|
|
28
Procter & Gamble
PG
$365B
| $10.5M | 0.6% |
70,672
+2,759
| +4% | +$394K |
2013 Q2
39 quarters
|
|
29
Goldman Sachs
GS
$260B
| $10.4M | 0.6% |
31,897
+1,207
| +4% | +$420K |
2013 Q2
39 quarters
|
|
30
RTX Corp
RTX
$252B
| $10.3M | 0.59% |
105,027
+1,037
| +1% | +$102K |
2013 Q2
39 quarters
|
|
31
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.16B
| $10.1M | 0.58% |
267,839
+60,249
| +29% | +$2.27M |
2022 Q1
4 quarters
|
|
32
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $10.1M | 0.58% |
95,573
-1,705
| -2% | -$183K |
2013 Q2
39 quarters
|
|
33
Broadcom
AVGO
$1.64T
| $9.65M | 0.55% |
150,490
+1,320
| +0.9% | +$79.4K |
2014 Q4
33 quarters
|
|
|
34
DELISTED
iShares Frontier and Select EM ETF
FM
| $9.22M | 0.53% |
360,351
+329,148
| +1,055% | +$8.44M |
2017 Q1
24 quarters
|
|
35
D.R. Horton
DHI
$39B
| $9.19M | 0.53% |
94,098
+352
| +0.4% | +$33.6K |
2017 Q1
24 quarters
|
|
36
Motorola Solutions
MSI
$75.5B
| $9.12M | 0.52% |
31,884
+443
| +1% | +$117K |
2019 Q4
13 quarters
|
|
37
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
| $8.95M | 0.51% |
163,930
+9,571
| +6% | +$519K |
2021 Q1
8 quarters
|
|
38
Visa
V
$750B
| $8.9M | 0.51% |
39,474
+1,209
| +3% | +$269K |
2013 Q2
39 quarters
|
|
39
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $8.88M | 0.51% |
81,274
+51,370
| +172% | +$5.58M |
2020 Q4
9 quarters
|
|
40
iShares Core S&P Small-Cap ETF
IJR
$103B
| $8.49M | 0.49% |
87,827
-34,160
| -28% | -$3.42M |
2013 Q2
39 quarters
|
|
41
Elevance Health
ELV
$92.9B
| $8.46M | 0.48% |
18,394
+108
| +0.6% | +$51.4K |
2017 Q2
23 quarters
|
|
42
JPMorgan Core Plus Bond ETF
JCPB
$15.8B
| $8.28M | 0.47% |
174,681
-10,625
| -6% | -$499K |
2020 Q1
12 quarters
|
|
43
Morgan Stanley
MS
$286B
| $8.15M | 0.47% |
92,808
+1,970
| +2% | +$184K |
2017 Q3
22 quarters
|
|
44
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
| $8.09M | 0.46% |
98,429
+94,611
| +2,478% | +$7.71M |
2022 Q2
3 quarters
|
|
45
iShares US Medical Devices ETF
IHI
$3.75B
| $7.8M | 0.45% |
144,461
-20,229
| -12% | -$1.08M |
2021 Q1
8 quarters
|
|
46
Schwab US Dividend Equity ETF
SCHD
$114B
| $7.73M | 0.44% |
316,923
+20,301
| +7% | +$508K |
2019 Q1
16 quarters
|
|
47
Air Products & Chemicals
APD
$66B
| $7.71M | 0.44% |
26,828
+623
| +2% | +$182K |
2017 Q2
23 quarters
|
|
48
Vanguard Morningstar Growth ETF
VUG
$232B
| $7.69M | 0.44% |
184,932
+20,334
| +12% | +$791K |
2018 Q1
20 quarters
|
|
49
Vanguard Dividend Appreciation ETF
VIG
$113B
| $7.64M | 0.44% |
49,637
+915
| +2% | +$140K |
2016 Q3
26 quarters
|
|
50
Zoetis
ZTS
$32.4B
| $7.53M | 0.43% |
45,263
+1,770
| +4% | +$290K |
2019 Q1
16 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q1 2023 Portfolio in Review
As of Q1 2023, Capital Analysts LLC held 1,098 positions worth $1.75B, up 6.7% from $1.64B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Capital Analysts LLC deployed $55.5M of net new capital in Q1 2023, opening 45 new positions and adding to 357 existing holdings. Its largest new stake was First Republic Bank: 7,795 shares worth $109K.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 70% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $31.6M trimmed.
- Capital Analysts LLC's largest Q1 2023 buy was First Republic Bank: 7,795 shares worth $109K.
- Capital Analysts LLC added most to iShares Core MSCI EAFE ETF in Q1 2023, an estimated $27.5M increase.
- Capital Analysts LLC's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $31.6M.
- Capital Analysts LLC fully exited VanEck Morningstar Wide Moat ETF in Q1 2023, selling an estimated $3.9M.
- Capital Analysts LLC's ten largest holdings make up 33% of its $1.75B portfolio in Q1 2023.
- Capital Analysts LLC opened 45 new positions and closed 132 in Q1 2023.
- Capital Analysts LLC's portfolio value rose 6.7% quarter-over-quarter to $1.75B.
Based on Capital Analysts LLC's 13F filing for Q1 2023, filed 5 May 2023.